| Year |
Citation |
Score |
| 2024 |
Smith D, Eichinger A, Rech A, Wang J, Esteva E, Seyedian A, Yang X, Zhang M, Martinez D, Tan K, Luo M, Park C, Reizis B, Pillai V. Spatial and Single Cell Mapping of Castleman Disease Reveals Key Stromal Cell Types and Cytokine Pathways. Biorxiv : the Preprint Server For Biology. PMID 39314418 DOI: 10.1101/2024.09.09.609717 |
0.351 |
|
| 2024 |
Elias HK, Mitra S, da Silva MB, Rajagopalan A, Gipson B, Lee N, Kousa AI, Ali MAE, Grassman S, Zhang X, DeWolf S, Smith M, Andrlova H, Argyropoulos KV, Sharma R, ... ... Park CY, et al. Low Kit expression identifies Hematopoietic Stem Cell subsets with enhanced lymphoid potential in mice and humans. Biorxiv : the Preprint Server For Biology. PMID 38895335 DOI: 10.1101/2024.06.06.597775 |
0.353 |
|
| 2024 |
Silva SLR, Dias IRSB, Rodrigues ACBDC, Costa RGA, Oliveira MS, Barbosa GADC, Soares MBP, Dias RB, Valverde LF, Rocha CAG, Roy N, Park CY, Bezerra DP. Emetine induces oxidative stress, cell differentiation and NF-κB inhibition, suppressing AML stem/progenitor cells. Cell Death Discovery. 10: 201. PMID 38684672 DOI: 10.1038/s41420-024-01967-8 |
0.403 |
|
| 2024 |
Sreejit G, Park CY. (Reg)ulation of hematopoietic lineage fates. Blood. 143: 188-190. PMID 38236614 DOI: 10.1182/blood.2023023000 |
0.31 |
|
| 2022 |
Chakraborty S, Park CY. Pathogenic Mechanisms in Acute Myeloid Leukemia. Current Treatment Options in Oncology. PMID 36190670 DOI: 10.1007/s11864-022-01021-8 |
0.339 |
|
| 2022 |
Stranahan AW, Berezniuk I, Chakraborty S, Feller F, Khalaj M, Park CY. Leukotrienes promote stem cell self-renewal and chemoresistance in acute myeloid leukemia. Leukemia. PMID 35461365 DOI: 10.1038/s41375-022-01579-0 |
0.797 |
|
| 2021 |
Zhan D, Park CY. Stem Cells in the Myelodysplastic Syndromes. Frontiers in Aging. 2: 719010. PMID 35822030 DOI: 10.3389/fragi.2021.719010 |
0.325 |
|
| 2020 |
Spevak CC, Elias HK, Kannan L, Ali MAE, Martin GH, Selvaraj S, Eng WS, Ernlund A, Rajasekhar VK, Woolthuis CM, Zhao G, Ha CJ, Schneider RJ, Park CY. Hematopoietic Stem and Progenitor Cells Exhibit Stage-Specific Translational Programs via mTOR- and CDK1-Dependent Mechanisms. Cell Stem Cell. 26: 755-765.e7. PMID 32386556 DOI: 10.1016/J.Stem.2019.12.006 |
0.435 |
|
| 2020 |
Ramalingam P, Poulos MG, Lazzari E, Gutkin MC, Lopez D, Kloss CC, Crowley MJ, Katsnelson L, Freire AG, Greenblatt MB, Park CY, Butler JM. Chronic activation of endothelial MAPK disrupts hematopoiesis via NFKB dependent inflammatory stress reversible by SCGF. Nature Communications. 11: 666. PMID 32015345 DOI: 10.1038/S41467-020-14478-8 |
0.373 |
|
| 2019 |
Guillamot M, Ouazia D, Dolgalev I, Yeung ST, Kourtis N, Dai Y, Corrigan K, Zea-Redondo L, Saraf A, Florens L, Washburn MP, Tikhonova AN, Malumbres M, Gong Y, Tsirigos A, ... Park C, et al. The E3 ubiquitin ligase SPOP controls resolution of systemic inflammation by triggering MYD88 degradation. Nature Immunology. PMID 31406379 DOI: 10.1038/S41590-019-0454-6 |
0.362 |
|
| 2019 |
Martin GH, Roy N, Chakraborty S, Desrichard A, Chung SS, Woolthuis CM, Hu W, Berezniuk I, Garrett-Bakelman FE, Hamann J, Devlin SM, Chan TA, Park CY. CD97 is a critical regulator of acute myeloid leukemia stem cell function. The Journal of Experimental Medicine. PMID 31371381 DOI: 10.1084/Jem.20190598 |
0.491 |
|
| 2019 |
Del Rey Gonzalez M, Park CY. Deconstructing myelodysplastic syndromes. Blood. 134: 106-107. PMID 31296543 DOI: 10.1182/Blood.2019001179 |
0.396 |
|
| 2019 |
Spevak CC, Park CY. Novel Mechanism Regulates c-Myc Expression in Diffuse Large B-cell Lymphoma. Journal of the National Cancer Institute. PMID 31114884 DOI: 10.1093/Jnci/Djz104 |
0.308 |
|
| 2019 |
Pang WW, Czechowicz A, Logan AC, Bhardwaj R, Poyser J, Park CY, Weissman IL, Shizuru JA. Anti-CD117 antibody depletes normal and myelodysplastic syndrome human hematopoietic stem cells in xenografted mice. Blood. PMID 30745302 DOI: 10.1182/Blood-2018-06-858159 |
0.828 |
|
| 2019 |
Ha CJ, Hu W, Elias HK, Chakraborty S, Park CY. Mir-29 Maintains the Acute Myeloid Leukemia Epigenome By Regulating CBX2 Blood. 134: 1236-1236. DOI: 10.1182/Blood-2019-131518 |
0.455 |
|
| 2019 |
Elias HK, Spevak C, Kannan L, Ali MA, Martin GH, Selvaraj S, Eng WS, Zhao G, Ernlund A, Rajasekhar V, Woolthuis CM, Schneider RJ, Park CY. Unique Regulatory Pathways Dictate the Translational Program in Hematopoietic Stem and Progenitor Cells Blood. 134: 1180-1180. DOI: 10.1182/Blood-2019-131333 |
0.37 |
|
| 2019 |
Elias HK, Shin JY, Ali MA, Chakraborty S, Ha CJ, Dolgalev I, Konishi C, Beerman I, Park CY. Identification of Old HSCs with Preserved Self-Renewal and Long-Term Reconstitution Potential Blood. 134: 2479-2479. DOI: 10.1182/Blood-2019-129508 |
0.346 |
|
| 2019 |
Park C, Martin G, Roy N, Chakraborty S, Desrichard A, chung S, Woolthuis C, Hu W, berezniuk I, Garrett-Bakelman F, Hamann J, Devlin s, chan T. 1018 - CD97 IS A CRITICAL REGULATOR OF ACUTE MYELOID LEUKEMIA STEM CELL FUNCTION Experimental Hematology. 76: S31. DOI: 10.1016/J.Exphem.2019.06.256 |
0.511 |
|
| 2018 |
Tavakkoli M, Chung SS, Park CY. Do preclinical studies suggest that CD99 is a potential therapeutic target in acute myeloid leukemia and the myelodysplastic syndromes? Expert Opinion On Therapeutic Targets. PMID 29637789 DOI: 10.1080/14728222.2018.1464140 |
0.546 |
|
| 2018 |
Martin GH, Park CY. Meddling with METTLs in Normal and Leukemia Stem Cells. Cell Stem Cell. 22: 139-141. PMID 29395048 DOI: 10.1016/J.Stem.2018.01.013 |
0.469 |
|
| 2018 |
Spevak C, Elias H, Kannan L, Martin G, Selvaraj S, Eng W, Ernlund A, Rajasekhar V, Woolthuis C, Schneider R, Park CY. Mtor-Independent Translation in Early Hematopoietic Development Blood. 132: 3827-3827. DOI: 10.1182/Blood-2018-99-120191 |
0.352 |
|
| 2018 |
Chung S, Hu W, Guo L, Park C. CD99 Regulates Normal and Malignant Hematopoietic Stem Cell Function by Restricting Protein Translation Experimental Hematology. 64: S58-S59. DOI: 10.1016/J.Exphem.2018.06.203 |
0.511 |
|
| 2018 |
Pang WW, Czechowicz A, Poyser J, Park CY, Weissman IL, Shizuru JA. Anti-Human CD117 Antibodies Mediate Clearance of Myelodysplastic Syndrome Hematopoietic Stem Cells and Facilitate Establishment of Normal Hematopoiesis in Transplantation Biology of Blood and Marrow Transplantation. 24: S230-S231. DOI: 10.1016/J.Bbmt.2017.12.211 |
0.823 |
|
| 2017 |
Chung SS, Park CY. Aging, hematopoiesis, and the myelodysplastic syndromes. Blood Advances. 1: 2572-2578. PMID 29296910 DOI: 10.1182/Bloodadvances.2017009852 |
0.385 |
|
| 2017 |
Chung SS, Park CY. Aging, hematopoiesis, and the myelodysplastic syndromes. Hematology. American Society of Hematology. Education Program. 2017: 73-78. PMID 29222239 DOI: 10.1182/Asheducation-2017.1.73 |
0.385 |
|
| 2017 |
Cimmino L, Dolgalev I, Wang Y, Yoshimi A, Martin GH, Wang J, Ng V, Xia B, Witkowski MT, Mitchell-Flack M, Grillo I, Bakogianni S, Ndiaye-Lobry D, Martín MT, Guillamot M, ... ... Park CY, et al. Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression. Cell. PMID 28823558 DOI: 10.1016/J.Cell.2017.07.032 |
0.439 |
|
| 2017 |
Khalaj M, Woolthuis CM, Hu W, Durham BH, Chu SH, Qamar S, Armstrong SA, Park CY. miR-99 regulates normal and malignant hematopoietic stem cell self-renewal. The Journal of Experimental Medicine. PMID 28733386 DOI: 10.1084/Jem.20161595 |
0.797 |
|
| 2017 |
Khalaj M, Park CY. snoRNAs contribute to myeloid leukaemogenesis. Nature Cell Biology. 19: 758-760. PMID 28659642 DOI: 10.1038/Ncb3566 |
0.763 |
|
| 2017 |
Martin GH, Park CY. EPCR: a novel marker of cultured cord blood HSCs. Blood. 129: 3279-3280. PMID 28642358 DOI: 10.1182/Blood-2017-05-780007 |
0.37 |
|
| 2017 |
Durham BH, Roos-Weil D, Baillou C, Cohen-Aubart F, Yoshimi A, Miyara M, Papo M, Hélias-Rodzewicz Z, Terrones N, Ozkaya N, Dogan A, Rampal R, Urbain F, Le Fèvre L, Diamond EL, ... Park CY, et al. Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells. Blood. PMID 28566492 DOI: 10.1182/Blood-2016-12-757377 |
0.49 |
|
| 2017 |
Chung SS, Eng WS, Hu W, Khalaj M, Garrett-Bakelman FE, Tavakkoli M, Levine RL, Carroll M, Klimek VM, Melnick AM, Park CY. CD99 is a therapeutic target on disease stem cells in myeloid malignancies. Science Translational Medicine. 9. PMID 28123069 DOI: 10.1126/Scitranslmed.Aaj2025 |
0.832 |
|
| 2017 |
Elias HK, Bryder D, Park CY. Molecular mechanisms underlying lineage bias in aging hematopoiesis. Seminars in Hematology. 54: 4-11. PMID 28088987 DOI: 10.1053/J.Seminhematol.2016.11.002 |
0.657 |
|
| 2017 |
Chung S, Vijay P, Klimek V, Mason C, Park C. An Analysis of the Transcriptional Response of Myelodysplastic Syndrome Stem Cells to Therapy at Single-Cell Resolution Leukemia Research. 55: S6-S7. DOI: 10.1182/Blood.V128.22.960.960 |
0.444 |
|
| 2017 |
Chung S, Vijay P, Klimek V, Mason C, Park C. An analysis of the transcriptional response of myelodysplastic syndrome stem cells to therapy at single-cell resolution Experimental Hematology. 53: S115. DOI: 10.1016/J.Exphem.2017.06.287 |
0.427 |
|
| 2016 |
Elias HK, Khalaj M, Park CY. Divergent roles of in normal and malignant stem cells. Translational Cancer Research. 5: S328-S331. PMID 33088733 DOI: 10.21037/tcr.2016.07.15 |
0.804 |
|
| 2016 |
Xu H, Valerio DG, Eisold ME, Sinha A, Koche RP, Hu W, Chen CW, Chu SH, Brien GL, Park CY, Hsieh JJ, Ernst P, Armstrong SA. NUP98 Fusion Proteins Interact with the NSL and MLL1 Complexes to Drive Leukemogenesis. Cancer Cell. PMID 27889185 DOI: 10.1016/J.Ccell.2016.10.019 |
0.313 |
|
| 2016 |
Ye H, Adane B, Khan N, Sullivan T, Minhajuddin M, Gasparetto M, Stevens B, Pei S, Balys M, Ashton JM, Klemm DJ, Woolthuis CM, Stranahan AW, Park CY, Jordan CT. Leukemic Stem Cells Evade Chemotherapy by Metabolic Adaptation to an Adipose Tissue Niche. Cell Stem Cell. PMID 27374788 DOI: 10.1016/J.Stem.2016.06.001 |
0.474 |
|
| 2016 |
Li S, Garrett-Bakelman FE, Chung SS, Sanders MA, Hricik T, Rapaport F, Patel J, Dillon R, Vijay P, Brown AL, Perl AE, Cannon J, Bullinger L, Luger S, Becker M, ... ... Park CY, et al. Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia. Nature Medicine. PMID 27322744 DOI: 10.1038/Nm.4125 |
0.311 |
|
| 2016 |
Woolthuis CM, Park CY. Hematopoietic stem/progenitor cell commitment to the megakaryocyte lineage. Blood. PMID 26787736 DOI: 10.1182/Blood-2015-07-607945 |
0.439 |
|
| 2016 |
Elias HK, Khalaj M, Park CY. Divergent roles of miR-126 in normal and malignant stem cells Translational Cancer Research. 5. DOI: 10.21037/8804 |
0.819 |
|
| 2016 |
Durham BH, Yoshimi A, Papo M, Chung YR, Ozkaya N, Ganzel C, Dogan A, Hyman DM, Park CY, Rampal RK, Roos Weil D, Lemoine FM, Amoura Z, Bernard OA, Diamond EL, et al. Frequent Clinical Overlap of Histiocytic Neoplasms and WHO-Classified Myeloid Malignancies Leads to Functional Insights into the Cell-of-Origin of Histiocytoses Blood. 128: 951-951. DOI: 10.1182/Blood.V128.22.951.951 |
0.413 |
|
| 2016 |
Rapaport F, de Massy MR, al Hinai A, Sanders MA, Hricik T, Sheridan C, Lee TC, Neelamraju Y, Patel J, Chung SS, Becker MW, Lewis ID, D'Andrea R, Bullinger L, Döhner K, ... ... Park CY, et al. Changes of the Mutational Landscape in Relapsed Acute Myeloid Leukemia Blood. 128: 599-599. DOI: 10.1182/Blood.V128.22.599.599 |
0.311 |
|
| 2016 |
Samaraweera SE, Garrett-Bakelman FE, Neelamraju Y, Perugini M, Casolari DA, Iarossi D, Bray SC, Sheridan C, Lee TC, Tiong IS, Danner S, Cummings N, Guzman ML, Roboz GJ, To LB, ... ... Park CY, et al. Hypermethylation of GADD45A Defines a Methylation Profile Distinct to Mutant IDH1/2, and Correlates with More Aggressive AML Blood. 128: 2877-2877. DOI: 10.1182/Blood.V128.22.2877.2877 |
0.312 |
|
| 2016 |
Khalaj M, Woolthuis C, Hu W, Durham BH, Park CY. Mir-99 Regulates Normal and Leukemic Stem Cell Function Blood. 128: 1469-1469. DOI: 10.1182/Blood.V128.22.1469.1469 |
0.791 |
|
| 2015 |
Mulero-Navarro S, Sevilla A, Roman AC, Lee DF, D'Souza SL, Pardo S, Riess I, Su J, Cohen N, Schaniel C, Rodriguez NA, Baccarini A, Brown BD, Cavé H, Caye A, ... ... Park CY, et al. Myeloid Dysregulation in a Human Induced Pluripotent Stem Cell Model of PTPN11-Associated Juvenile Myelomonocytic Leukemia. Cell Reports. 13: 504-515. PMID 26456833 DOI: 10.1016/J.Celrep.2015.09.019 |
0.45 |
|
| 2015 |
Ke S, Alemu EA, Mertens C, Gantman EC, Fak JJ, Mele A, Haripal B, Zucker-Scharff I, Moore MJ, Park CY, Vågbø CB, Kuśnierczyk A, Klungland A, Darnell JE, Darnell RB. A majority of m6A residues are in the last exons, allowing the potential for 3' UTR regulation. Genes & Development. PMID 26404942 DOI: 10.1101/Gad.269415.115 |
0.387 |
|
| 2015 |
Tiacci E, Park JH, De Carolis L, Chung SS, Broccoli A, Scott S, Zaja F, Devlin S, Pulsoni A, Chung YR, Cimminiello M, Kim E, Rossi D, Stone RM, Motta G, ... ... Park CY, et al. Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia. The New England Journal of Medicine. PMID 26352686 DOI: 10.1056/Nejmoa1506583 |
0.353 |
|
| 2015 |
Raval A, Behbehani GK, Nguyen le XT, Thomas D, Kusler B, Garbuzov A, Ramunas J, Holbrook C, Park CY, Blau H, Nolan GP, Artandi SE, Mitchell BS. Reversibility of Defective Hematopoiesis Caused by Telomere Shortening in Telomerase Knockout Mice. Plos One. 10: e0131722. PMID 26133370 DOI: 10.1371/Journal.Pone.0131722 |
0.449 |
|
| 2015 |
Hu W, Dooley J, Chung SS, Chandramohan D, Cimmino L, Mukherjee S, Mason CE, de Strooper B, Liston A, Park CY. miR-29a maintains mouse hematopoietic stem cell self-renewal by regulating Dnmt3a. Blood. 125: 2206-16. PMID 25634742 DOI: 10.1182/Blood-2014-06-585273 |
0.376 |
|
| 2015 |
Poulos MG, Gutkin M, Park CY, Butler JM. Rejuvenation of Aged Vascular Niches to Enhance Hematopoietic Function Blood. 126: 781-781. DOI: 10.1182/Blood.V126.23.781.781 |
0.422 |
|
| 2015 |
Chung SS, Vijay P, Stern DL, O'Sullivan D, Klimek VM, Mason C, Park CY. Analysis of Myelodysplastic Syndrome Stem Cells at Single Cell Resolution during DNA Methyltransferase Inhibitor Therapy Blood. 126: 4101-4101. DOI: 10.1182/Blood.V126.23.4101.4101 |
0.411 |
|
| 2015 |
Khalaj M, Hu W, Park CY. Mir-99 Is a Regulator of Hematopoietic and Leukemic Stem Cell Differentiation Blood. 126: 3063-3063. DOI: 10.1182/Blood.V126.23.3063.3063 |
0.802 |
|
| 2015 |
Garrett-Bakelman FE, Li S, Chung SS, Hricik T, Franck R, Patel J, Dillon R, Vijay P, Brown AL, Perl AE, Cannon BJ, Sanders MA, Valk PJM, Bullinger L, Luger S, ... ... Park CY, et al. Divergent Dynamics of Epigenetic and Genetic Heterogeneity in Relapsed Acute Myeloid Leukemia Blood. 126: 306-306. DOI: 10.1182/Blood.V126.23.306.306 |
0.335 |
|
| 2015 |
Tavakkoli M, Lee DH, Durham B, Chung SS, Park CY. Targeting CD99 in T-Cell Neoplasms with Monoclonal Antibodies Blood. 126: 2749-2749. DOI: 10.1182/Blood.V126.23.2749.2749 |
0.457 |
|
| 2015 |
Hu W, Park CY. Desuppressed Expressionsof MiR-29 targetsdisturb the Leukemeugenesis of MLL-AF9 Blood. 126: 1228-1228. DOI: 10.1182/Blood.V126.23.1228.1228 |
0.396 |
|
| 2015 |
Tavakkoli M, Lee DH, Chung SS, Park CY. Abstract 3566: Targeting CD99 in T-cell neoplasms Cancer Research. 75: 3566-3566. DOI: 10.1158/1538-7445.Am2015-3566 |
0.434 |
|
| 2015 |
Park CY, Vijay P, Chung SS, Stern D, Klimek V, Mason CE. Declined presentation single-cell analysis of myelodysplastic sydrome stem cells during therapy and disease progression Experimental Hematology. 43: S88. DOI: 10.1016/J.Exphem.2015.06.224 |
0.425 |
|
| 2014 |
Rampal R, Ahn J, Abdel-Wahab O, Nahas M, Wang K, Lipson D, Otto GA, Yelensky R, Hricik T, McKenney AS, Chiosis G, Chung YR, Pandey S, van den Brink MR, Armstrong SA, ... ... Park CY, et al. Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms. Proceedings of the National Academy of Sciences of the United States of America. 111: E5401-10. PMID 25516983 DOI: 10.1073/Pnas.1407792111 |
0.365 |
|
| 2014 |
Abdel-Wahab O, Park CY. BRAF-mutant hematopoietic malignancies. Oncotarget. 5: 7980-1. PMID 25478626 DOI: 10.18632/Oncotarget.2448 |
0.441 |
|
| 2014 |
Khalaj M, Tavakkoli M, Stranahan AW, Park CY. Pathogenic microRNA's in myeloid malignancies. Frontiers in Genetics. 5: 361. PMID 25477897 DOI: 10.3389/Fgene.2014.00361 |
0.77 |
|
| 2014 |
Hu W, Park CY. Measuring microRNA expression in mouse hematopoietic stem cells. Methods in Molecular Biology (Clifton, N.J.). 1185: 121-40. PMID 25062625 DOI: 10.1007/978-1-4939-1133-2_8 |
0.359 |
|
| 2014 |
Khalaj M, Park CY. Notch one up to stroma: endothelial notch prevents inflammation and myeloproliferation. Cell Stem Cell. 15: 1-2. PMID 24996160 DOI: 10.1016/J.Stem.2014.06.010 |
0.792 |
|
| 2014 |
Chung SS, Kim E, Park JH, Chung YR, Lito P, Teruya-Feldstein J, Hu W, Beguelin W, Monette S, Duy C, Rampal R, Telis L, Patel M, Kim MK, Huberman K, ... ... Park CY, et al. Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemia. Science Translational Medicine. 6: 238ra71. PMID 24871132 DOI: 10.1126/Scitranslmed.3008004 |
0.482 |
|
| 2014 |
Shin JY, Hu W, Naramura M, Park CY. High c-Kit expression identifies hematopoietic stem cells with impaired self-renewal and megakaryocytic bias. The Journal of Experimental Medicine. 211: 217-31. PMID 24446491 DOI: 10.1084/Jem.20131128 |
0.325 |
|
| 2014 |
Yoo M, Lee GA, Park C, Cohen RI, Schachner M. Analysis of human embryonic stem cells with regulatable expression of the cell adhesion molecule l1 in regeneration after spinal cord injury. Journal of Neurotrauma. 31: 553-64. PMID 24125017 DOI: 10.1089/neu.2013.2886 |
0.304 |
|
| 2014 |
Perugini M, Samaraweera SE, Brown AL, Cummings N, Danner S, Tiong IS, Garrett-Bakelman FE, Carroll MP, Becker MW, Chung SS, Park CY, Mason CE, Guzman ML, Levine RL, Melnick AM, et al. The Significance of GADD45A Promoter DNA Hypermethylation in AML: Association with IDH1/2 and TET2 Mutation Blood. 124: 69-69. DOI: 10.1182/Blood.V124.21.69.69 |
0.326 |
|
| 2014 |
Yalcin S, Carty M, Shin JY, Miller RA, Leslie C, Park CY. Microrna Mediated Regulation of Hematopoietic Stem Cell Aging Blood. 124: 602-602. DOI: 10.1182/Blood.V124.21.602.602 |
0.473 |
|
| 2014 |
Hu W, Dooley J, Cimmino L, Liston A, Park CY. MiR-29a is Essential in Leukemic Transformation and Maintaining Hematopoietic Stem Cell Self-Renewal Blood. 124: 4792-4792. DOI: 10.1182/Blood.V124.21.4792.4792 |
0.375 |
|
| 2014 |
Chung SS, Tavakkoli M, Klimek VM, Park CY. CD99 Is a Therapeutic Target on Disease Initiating Stem Cells in Acute Myeloid Leukemia and the Myelodysplastic Syndromes Blood. 124: 3760-3760. DOI: 10.1182/BLOOD.V124.21.3760.3760 |
0.391 |
|
| 2014 |
Kim E, Chung SS, Park JH, Chung YR, Lito P, Feldstein J, Hu W, Beguilin W, Monette S, Duy C, Rampal R, Telis L, Patel M, Kim MK, Melnick AM, ... ... Park CY, et al. Abstract 3140: Context specific effects of the BRAFV600E mutation on hematopoiesis identifies novel models of BRAF mutant hematopoietic disorders Cancer Research. 74: 3140-3140. DOI: 10.1158/1538-7445.Am2014-3140 |
0.453 |
|
| 2014 |
Chung S, Kim E, Park J, Chung YR, Tallman M, Abdel-Wahab O, Park C. BRAFV600E mutations occur in hematopoietic stem cells in hairy cell leukemia Experimental Hematology. 42: S29. DOI: 10.1016/J.Exphem.2014.07.102 |
0.45 |
|
| 2014 |
Park C, Yalcin S, Carty M, Shin J, Miller R, Leslie C. Anti-aging interventions reverse hematopoietic stem cell aging via regulation of micrornas Experimental Hematology. 42: S21. DOI: 10.1016/J.Exphem.2014.07.074 |
0.388 |
|
| 2014 |
Chung S, Klimek V, Park C. CD99 is a therapeutic target on disease stem cells in acute myeloid leukemia and the myelodysplastic syndromes Experimental Hematology. 42: S20. DOI: 10.1016/J.Exphem.2014.07.071 |
0.49 |
|
| 2014 |
Chung SS, Devlin S, Park CY. CD99 Identifies Disease Stem Cells in Acute Myeloid Leukemia (AML) and the Myelodysplastic Syndromes (MDS) Clinical Lymphoma Myeloma and Leukemia. 14: S121. DOI: 10.1016/J.Clml.2014.06.041 |
0.498 |
|
| 2014 |
Yalcin S, Chung SS, Park CY. The role of MicroRNAs in hematopoietic stem cells and leukemia development Microrna in Development and in the Progression of Cancer. 139-157. DOI: 10.1007/978-1-4899-8065-6_8 |
0.382 |
|
| 2014 |
Chung SS, Park CY. Acute Myeloid Leukemia Stem Cells-Updates and Controversies Cancer Stem Cells. 143-160. DOI: 10.1002/9781118356203.ch11 |
0.358 |
|
| 2013 |
Abdel-Wahab O, Gao J, Adli M, Dey A, Trimarchi T, Chung YR, Kuscu C, Hricik T, Ndiaye-Lobry D, Lafave LM, Koche R, Shih AH, Guryanova OA, Kim E, Li S, ... ... Park CY, et al. Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo. The Journal of Experimental Medicine. 210: 2641-59. PMID 24218140 DOI: 10.1084/Jem.20131141 |
0.462 |
|
| 2013 |
Deshpande S, Bosbach B, Yozgat Y, Park CY, Moore MA, Besmer P. KIT receptor gain-of-function in hematopoiesis enhances stem cell self-renewal and promotes progenitor cell expansion. Stem Cells (Dayton, Ohio). 31: 1683-95. PMID 23681919 DOI: 10.1002/Stem.1419 |
0.43 |
|
| 2013 |
Pang WW, Pluvinage JV, Price EA, Sridhar K, Arber DA, Greenberg PL, Schrier SL, Park CY, Weissman IL. Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes. Proceedings of the National Academy of Sciences of the United States of America. 110: 3011-6. PMID 23388639 DOI: 10.1073/Pnas.1222861110 |
0.811 |
|
| 2013 |
Lobry C, Ntziachristos P, Ndiaye-Lobry D, Oh P, Cimmino L, Zhu N, Araldi E, Hu W, Freund J, Abdel-Wahab O, Ibrahim S, Skokos D, Armstrong SA, Levine RL, Park CY, et al. Notch pathway activation targets AML-initiating cell homeostasis and differentiation. The Journal of Experimental Medicine. 210: 301-19. PMID 23359070 DOI: 10.1084/Jem.20121484 |
0.37 |
|
| 2013 |
Chung SS, Park JH, Kim E, Chung YR, Hu W, Lito P, Feldstein JT, Rampal RK, Telis L, Patel M, Rosen N, Park CY, Tallman MS, Abdel-Wahab O. BRAFV600E Mutations Occur In The Hematopoietic Stem Cell Compartment In Hairy Cell Leukemia Blood. 122: 816-816. DOI: 10.1182/Blood.V122.21.816.816 |
0.528 |
|
| 2013 |
Garrett-Bakelman FE, Li S, Hricik T, Chung SS, Bar H, Brown AL, Patel JP, Rapoport F, Liu L, Sheridan C, Ishii J, Zumbo P, Gandara J, Lewis ID, To LB, ... ... Park CY, et al. Epigenetic Deregulation In Relapsed Acute Myeloid Leukemia Blood. 122: 2499-2499. DOI: 10.1182/Blood.V122.21.2499.2499 |
0.339 |
|
| 2013 |
Hu W, Dooley J, Chung SS, Yalcin S, Shin YS, De Strooper B, Liston A, Park CY. MiR-29a Maintains Hematopoietic Stem Cell Self-Renewal and Is Required For Myeloid Leukemogenesis Blood. 122: 1190-1190. DOI: 10.1182/Blood.V122.21.1190.1190 |
0.379 |
|
| 2013 |
Yalcin S, Hu W, Miller RA, Shin Y, Park CY. Longevity Promoting Interventions Inhibit Molecular and Functional Changes In Aging Hematopoietic Stem Cells Blood. 122: 1168-1168. DOI: 10.1182/Blood.V122.21.1168.1168 |
0.379 |
|
| 2013 |
Park C, Pang W, Chung S, Pluvinage J, Price E, Sridhar K, Arber D, Greenberg P, Schrier S, Weissman I. O-009 Evaluation of hematopoietic stem/progenitor cells in MDS reveals novel pathogenic mechanisms Leukemia Research. 37: S12-S13. DOI: 10.1016/S0145-2126(13)70031-6 |
0.766 |
|
| 2013 |
Park C, Shin J, Yalcin S, Hu W. Low c-Kit expression identifies hematopoietic stem cells with enhanced self-renewal potential Experimental Hematology. 41: S43. DOI: 10.1016/J.Exphem.2013.05.171 |
0.429 |
|
| 2013 |
Park C, Hu W, Dooley J, Chung S, Shin YS, De Strooper B, Liston A. miR-29a maintains hematopoietic stem cell self-renewal and is required for leukemic transformation Experimental Hematology. 41: S43. DOI: 10.1016/J.Exphem.2013.05.170 |
0.415 |
|
| 2013 |
Chung S, Pang W, Jan M, Klimek V, Weissman I, Majeti R, Park C. CD99 identifies disease stem cells in acute myeloid leukemia (AML) and the myelodysplastic syndromes (MDS) Experimental Hematology. 41: S16. DOI: 10.1016/J.Exphem.2013.05.060 |
0.829 |
|
| 2012 |
Kim D, Park CY, Medeiros BC, Weissman IL. CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells. Leukemia. 26: 2530-7. PMID 22733078 DOI: 10.1038/Leu.2012.140 |
0.63 |
|
| 2012 |
Raval A, Kusler B, Pang WW, Weissman IL, Mitchell BS, Park CY. Effect of nucleophosmin1 haploinsufficiency on hematopoietic stem cells. Leukemia. 26: 853-5. PMID 21979879 DOI: 10.1038/Leu.2011.270 |
0.772 |
|
| 2012 |
Rampal RK, Pandey S, Abdel-Wahab O, Tsai JJ, Manshouri T, Park CY, Verstovsek S, Levine RL. Development of a Murine Model for Leukemic Transformation of Myeloproliferative Neoplasms for Preclinical Therapeutic Studies Blood. 120: 808-808. DOI: 10.1182/Blood.V120.21.808.808 |
0.416 |
|
| 2012 |
Levine RL, Koppikar P, Marubayashi S, Bhagwat N, Taldone T, Park CY, Chiosis G. Combination Therapy Using JAK2 and HSP90 Inhibitors Increased Efficacy in Myelofibrosis in Vivo Blood. 120: 805-805. DOI: 10.1182/Blood.V120.21.805.805 |
0.305 |
|
| 2012 |
Abdel-Wahab O, Gao J, Adli M, Chung YR, Koche R, Shih AH, Pandey S, La-Fave LM, Ndiaye-Lobry D, Shin YS, Bhatt PK, Patel JP, Zhao X, Park CY, Jaffe JD, et al. Conditional Deletion of Asxl1 Results in Myelodysplasia Blood. 120: 308-308. DOI: 10.1182/Blood.V120.21.308.308 |
0.361 |
|
| 2012 |
Shin JY, Hu W, Park CY. Differential Expression of c-Kit Identifies Hematopoietic Stem Cells with Variable Self-Renewal Potential. Blood. 120: 2325-2325. DOI: 10.1182/Blood.V120.21.2325.2325 |
0.375 |
|
| 2012 |
Chung SS, Pang WW, In GK, Jan M, Klimek VM, Melnick A, Weissman IL, Majeti R, Park CY. CD99 Identifies Disease Stem Cells in Acute Myeloid Leukemia and the Myelodysplastic Syndromes Blood. 120: 210-210. DOI: 10.1182/Blood.V120.21.210.210 |
0.799 |
|
| 2011 |
Chung SS, Hu W, Park CY. The Role of MicroRNAs in Hematopoietic Stem Cell and Leukemic Stem Cell Function. Therapeutic Advances in Hematology. 2: 317-34. PMID 23556099 DOI: 10.1177/2040620711410772 |
0.479 |
|
| 2011 |
Amrani YM, Gill J, Matevossian A, Alonzo ES, Yang C, Shieh JH, Moore MA, Park CY, Sant'Angelo DB, Denzin LK. The Paf oncogene is essential for hematopoietic stem cell function and development. The Journal of Experimental Medicine. 208: 1757-65. PMID 21844206 DOI: 10.1084/Jem.20102170 |
0.461 |
|
| 2011 |
McGowan KA, Pang WW, Bhardwaj R, Perez MG, Pluvinage JV, Glader BE, Malek R, Mendrysa SM, Weissman IL, Park CY, Barsh GS. Reduced ribosomal protein gene dosage and p53 activation in low-risk myelodysplastic syndrome. Blood. 118: 3622-33. PMID 21788341 DOI: 10.1182/Blood-2010-11-318584 |
0.74 |
|
| 2011 |
Chao MP, Alizadeh AA, Tang C, Jan M, Weissman-Tsukamoto R, Zhao F, Park CY, Weissman IL, Majeti R. Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia. Cancer Research. 71: 1374-84. PMID 21177380 DOI: 10.1158/0008-5472.Can-10-2238 |
0.722 |
|
| 2011 |
Park CY, Pang WW, Price E, Pluvinage JA, Schrier SL, Weissman IL. Hematopoietic Stem Cells Are the Disease-Initiating Cells in the Myelodysplastic Syndromes Blood. 118: 789-789. DOI: 10.1182/Blood.V118.21.789.789 |
0.81 |
|
| 2011 |
Hu W, Park CY. Leukemogenic MicroRNA-29a Causes Myeloproliferation by Inhibiting Apoptosis and Inducing Aberrant Self-Renewal in a Developmental Stage Specific Manner Blood. 118: 2556-2556. DOI: 10.1182/Blood.V118.21.2556.2556 |
0.422 |
|
| 2011 |
Czechowicz A, Bhardwaj R, Pang W, Park C, Weissman I. Targeted Clearance of Human Hematopoietic Stem Cell Niches Via Inhibition of SCF Signaling Using Monoclonal Antibody SR-1 Biology of Blood and Marrow Transplantation. 17: S187-S188. DOI: 10.1182/Blood.V116.21.74.74 |
0.826 |
|
| 2010 |
Chao MP, Jaiswal S, Weissman-Tsukamoto R, Alizadeh AA, Gentles AJ, Volkmer J, Weiskopf K, Willingham SB, Raveh T, Park CY, Majeti R, Weissman IL. Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47. Science Translational Medicine. 2: 63ra94. PMID 21178137 DOI: 10.1126/Scitranslmed.3001375 |
0.804 |
|
| 2010 |
Ooi AG, Sahoo D, Adorno M, Wang Y, Weissman IL, Park CY. MicroRNA-125b expands hematopoietic stem cells and enriches for the lymphoid-balanced and lymphoid-biased subsets. Proceedings of the National Academy of Sciences of the United States of America. 107: 21505-10. PMID 21118986 DOI: 10.1073/Pnas.1016218107 |
0.754 |
|
| 2010 |
Chao MP, Alizadeh AA, Tang C, Myklebust JH, Varghese B, Gill S, Jan M, Cha AC, Chan CK, Tan BT, Park CY, Zhao F, Kohrt HE, Malumbres R, Briones J, et al. Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma. Cell. 142: 699-713. PMID 20813259 DOI: 10.1016/J.Cell.2010.07.044 |
0.797 |
|
| 2010 |
Han YC, Park CY, Bhagat G, Zhang J, Wang Y, Fan JB, Liu M, Zou Y, Weissman IL, Gu H. MicroRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia Journal of Experimental Medicine. 207: 475-489. PMID 20212066 DOI: 10.1084/Jem.20090831 |
0.612 |
|
| 2010 |
Czechowicz A, Bhardwaj R, Park CY, Weissman IL. Targeted Clearance of Human Hematopoietic Stem Cell Niches Via Inhibition of SCF Signaling Using Monoclonal Antibody SR-1 Blood. 116: 74-74. DOI: 10.1182/BLOOD.V116.21.74.74 |
0.627 |
|
| 2010 |
Park CY, McGowan KA, Glader B, Barsh GS, Weissman IL. Haploinsufficiency of Ribosomal Protein S6 In Mice Mimics Bone Marrow Failure Syndromes In Humans Blood. 116: 194-194. DOI: 10.1182/Blood.V116.21.194.194 |
0.586 |
|
| 2010 |
Chao MP, Alizadeh AA, Tang CZ, Myklebust JH, Varghese B, Jan M, Cha AC, Tan BT, Park CY, Levy R, Weissman IL, Majeti R. Abstract 2440: CD47 is a prognostic factor and an antibody target that synergizes with rituximab to eradicate non-Hodgkin lymphoma Cancer Research. 70: 2440-2440. DOI: 10.1158/1538-7445.Am10-2440 |
0.716 |
|
| 2009 |
Jaiswal S, Jamieson CH, Pang WW, Park CY, Chao MP, Majeti R, Traver D, van Rooijen N, Weissman IL. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell. 138: 271-85. PMID 19632178 DOI: 10.1016/J.Cell.2009.05.046 |
0.819 |
|
| 2009 |
Park CY, Tseng D, Weissman IL. Cancer stem cell-directed therapies: Recent data from the laboratory and clinic Molecular Therapy. 17: 219-230. PMID 19066601 DOI: 10.1038/Mt.2008.254 |
0.794 |
|
| 2009 |
Raval A, Park CY, Pang WW, Kusler B, Sridhar KJ, Gotlib JR, Greenberg PL, Weissman IL, Mitchell BS. NPM1 Haploinsufficiency Results in Increased Numbers of Hematopoietic Stem Cells and Progenitor Cells. Blood. 114: 738-738. DOI: 10.1182/Blood.V114.22.738.738 |
0.802 |
|
| 2009 |
Park CY, Pang WW, Greenberg PL, Weissman IL. Myelodysplastic Syndromes Are Characterized by Gene Expression Changes in Hematopoietic Stem Cells and Alterations in Hematopoietic Stem Cell and Myeloid Progenitor Composition. Blood. 114: 1762-1762. DOI: 10.1182/Blood.V114.22.1762.1762 |
0.81 |
|
| 2008 |
Park CY, Majeti R, Weissman IL. In vivo evaluation of human hematopoiesis through xenotransplantation of purified hematopoietic stem cells from umbilical cord blood. Nature Protocols. 3: 1932-40. PMID 19180077 DOI: 10.1038/Nprot.2008.194 |
0.732 |
|
| 2008 |
Dulai MS, Park CY, Howell WD, Smyth LT, Desai M, Carter DM, Vogel H. CNS T-cell lymphoma: an under-recognized entity? Acta Neuropathologica. 115: 345-56. PMID 18196250 DOI: 10.1007/S00401-007-0338-Y |
0.31 |
|
| 2008 |
Chao MP, Weissman IL, Park CY. Cancer stem cells: On the verge of clinical translation Laboratory Medicine. 39: 679-686. DOI: 10.1309/Lmtddrgly374Wscq |
0.608 |
|
| 2008 |
Park CY, Han Y, Bhagat G, Fan J, Weissman IL, Gu H. MicroRNA-29a Is An Oncogene in Acute Myeloid Leukemia Blood. 112: 683-683. DOI: 10.1182/Blood.V112.11.683.683 |
0.622 |
|
| 2007 |
Majeti R, Park CY, Weissman IL. Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell. 1: 635-45. PMID 18371405 DOI: 10.1016/j.stem.2007.10.001 |
0.727 |
|
| 2007 |
Zhao W, Cha EN, Lee C, Park CY, Schindler C. Stat2-dependent regulation of MHC class II expression. Journal of Immunology (Baltimore, Md. : 1950). 179: 463-71. PMID 17579067 DOI: 10.4049/Jimmunol.179.1.463 |
0.69 |
|
| 2007 |
Hosen N, Park CY, Tatsumi N, Oji Y, Sugiyama H, Gramatzki M, Krensky AM, Weissman IL. CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia Proceedings of the National Academy of Sciences of the United States of America. 104: 11008-11013. PMID 17576927 DOI: 10.1073/Pnas.0704271104 |
0.761 |
|
| 2007 |
Park CY, Wang Y, Prohaska S, Tseng D, Weissman IL. MicroRNA Profiling of Human Acute Myeloid Leukemia and Normal Hematopoietic Stem/Progenitor Cells Reveals a Leukemia Stem Cell Signature. Blood. 110: 779-779. DOI: 10.1182/Blood.V110.11.779.779 |
0.791 |
|
| 2006 |
Tan BT, Park CY, Ailles LE, Weissman IL. The cancer stem cell hypothesis: a work in progress. Laboratory Investigation; a Journal of Technical Methods and Pathology. 86: 1203-7. PMID 17075578 DOI: 10.1038/Labinvest.3700488 |
0.627 |
|
| 2006 |
Park CY, Majeti R, Tan BT, Weissman IL. Development of a Novel Xenotransplantation System for Studying Human Acute Myeloid Leukemia. Blood. 108: 1947-1947. DOI: 10.1182/Blood.V108.11.1947.1947 |
0.756 |
|
| 2004 |
Park CY, Bohen SP, Levy R, Warnke RA, Natkunam Y. The Number of CD25+ Tumor-Infiltrating Cells May Predict Clinical Response to Rituximab in Follicular Lymphoma Patients. Blood. 104: 748-748. DOI: 10.1182/Blood.V104.11.748.748 |
0.413 |
|
| 2000 |
Park C, Li S, Cha E, Schindler C. Immune response in Stat2 knockout mice Immunity. 13: 795-804. PMID 11163195 DOI: 10.1016/S1074-7613(00)00077-7 |
0.69 |
|
| 1999 |
Park C, Lecomte M, Schindler C. Murine Stat2 is uncharacteristically divergent Nucleic Acids Research. 27: 4191-4199. PMID 10518610 DOI: 10.1093/Nar/27.21.4191 |
0.464 |
|
| 1998 |
Park C, Schindler C. Protein-DNA interactions in interferon-gamma signaling. Methods. 15: 175-188. PMID 9735303 DOI: 10.1006/Meth.1998.0622 |
0.441 |
|
| Show low-probability matches. |
